Kwaśny, Aleksander
Cubała, Wiesław Jerzy
Włodarczyk, Adam
Pastuszak, Krzysztof
Funding for this research was provided by:
Gdański Uniwersytet Medyczny (01-10024 / 0006051 / 01 / 221 / 221 / 0 / 2024)
Gdański Uniwersytet Medyczny (01-10024 / 0006051 / 01 / 221 / 221 / 0 / 2024)
Gdański Uniwersytet Medyczny (01-10024 / 0006051 / 01 / 221 / 221 / 0 / 2024)
Gdański Uniwersytet Medyczny (01-10024 / 0006051 / 01 / 221 / 221 / 0 / 2024)
Article History
Received: 18 May 2024
Revised: 13 August 2024
Accepted: 20 August 2024
First Online: 29 August 2024
Declarations
:
: Krzysztof Pastuszak has no conflict of interest. Aleksander Kwaśny has received research support: Beckley Psytech, GH Research, MSD. Adam Włodarczyk has received research support: KCR, Janssen, Otsuka, Apodemus, Novartis, Cortexyme, GH Research and Acadia. Wiesław Jerzy Cubała has received grants from Acadia, Angelini, Celon, Cortexyme, GH Research, HMNC Brain Health, IntraCellular Therapies, Janssen, MSD, Novartis, Otsuka. He has albo received honoraria from Angelini, Celon, Janssen, Novartis, Sanofi. He is a member of advisory boards in Angelini, Celon (terminated), Douglas Pharmaceuticals, Janssen, MSD, Novartis, Sanofi.